Literature DB >> 21223295

Evaluation of the overnight hold of whole blood at room temperature, before component processing: platelets (PLTs) from PLT-rich plasma.

Pieter F van der Meer1, Jose A Cancelas, Ralph R Vassallo, Neeta Rugg, Mindy Einarson, John R Hess.   

Abstract

BACKGROUND: Whole blood (WB) must be refrigerated within 8 hours to optimize Factor VIII: C yield, but chilled platelets (PLTs) are rapidly removed from circulation and cannot be used clinically. It is logistically preferable to hold WB overnight at room temperature for next-day processing. We compared in vitro quality of PLT-rich plasma (PRP)-derived PLT concentrates (PCs) from fresh versus overnight-held WB. STUDY DESIGN AND METHODS: Four units of WB were pooled and split to prevent donor-dependent differences. One unit was processed immediately; three others were held at room temperature and processed after 24 to 26 hours. After soft-spin centrifugation, PRP was separated from the red blood cells. PRP was hard-spun to make PLT-poor plasma, and the PLTs were resuspended in approximately 60 mL of plasma and stored for 7 days (n = 8 paired experiments by two blood centers).
RESULTS: After overnight hold, the PLT concentration was 1.37 × 10(9) ± 0.19 × 10(9) /mL versus 1.03 × 10(9) ± 0.32 × 10(9) /mL for freshly prepared PCs (p < 0.05). pH and glucose were significantly lower and lactate higher for overnight-held units on Day 1, but by Day 5, the differences had disappeared. Hypotonic shock response was initially better, 73 ± 14% for overnight-held versus 53 ± 12% for freshly processed (p < 0.001), but this difference also disappeared during storage. Activation marker CD62P was not different.
CONCLUSION: In vitro storage conditions produce immediate differences after preparation, which disappear throughout storage. PCs from overnight-held WB have similar in vitro variables as from freshly processed WB. These findings warrant confirmation in clinical trials, but underscore the possibility of use of these PCs as being equivalent to those obtained from freshly processed WB.
© 2010 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21223295     DOI: 10.1111/j.1537-2995.2010.02962.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  3 in total

1.  The purified vepoloxamer prevents haemolysis in 42-day stored, DEHP/PVC-free red blood cell units.

Authors:  Jose A Cancelas; Neeta Rugg; Shawnagay Nestheide; Sarah E Hill; R Martin Emanuele; Douglas S Mckenzie
Journal:  Blood Transfus       Date:  2017-03       Impact factor: 3.443

2.  Stationary versus agitated storage of whole blood during acute normovolemic hemodilution.

Authors:  Shu Yang Lu; Gerhardt Konig; Mark H Yazer; Jay P Brooks; Yi-Fan Chen; Jong-Hyeon Jeong; Jonathan H Waters
Journal:  Anesth Analg       Date:  2014-02       Impact factor: 5.108

3.  A comparison study of the blood component quality of whole blood held overnight at 4°c or room temperature.

Authors:  Shichun Wang; Tiantian Wang; Yahan Fan; Shan Huang; Zhongmei Yi; Ruiqing Li; Shuming Zhao
Journal:  J Blood Transfus       Date:  2013-09-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.